Her main research concerns Biochemistry, Cyclin-dependent kinase, Kinase, Cyclin-dependent kinase 2 and Cyclin-dependent kinase 1. In the subject of general Biochemistry, her work in Cyclin-dependent kinase complex, Glycoprotein, Phosphorylation and Histone H3 is often linked to P-glycoprotein, thereby combining diverse domains of study. The Cyclin-dependent kinase study which covers Cyclin that intersects with Cyclin-dependent kinase 5.
Her Kinase study improves the overall literature in Cell biology. Her Cyclin-dependent kinase 2 research incorporates themes from Protein structure and Stereochemistry. Her Cyclin-dependent kinase 1 research incorporates elements of Molecular biology and Cell growth.
Jane A. Endicott spends much of her time researching Cyclin-dependent kinase, Cell biology, Cyclin-dependent kinase 2, Biochemistry and Kinase. Jane A. Endicott combines subjects such as Cyclin-dependent kinase 1, Binding site and Cyclin with her study of Cyclin-dependent kinase. The study incorporates disciplines such as Cancer research and Purine in addition to Cyclin-dependent kinase 1.
Her work deals with themes such as Protein structure, Cell cycle, Ubiquitin and Cyclin D, which intersect with Cell biology. She interconnects Stereochemistry and Mitogen-activated protein kinase kinase in the investigation of issues within Cyclin-dependent kinase 2. Her studies examine the connections between Kinase and genetics, as well as such issues in Computational biology, with regards to Drug discovery.
Jane A. Endicott mainly investigates Cell biology, Cyclin-dependent kinase, Cyclin-dependent kinase 1, Cyclin-dependent kinase 2 and Kinase. The concepts of her Cell biology study are interwoven with issues in Genetics, Structural motif, Mutant and Nuclear transport. Her Cyclin-dependent kinase study combines topics from a wide range of disciplines, such as Binding site and Cyclin.
Her Cyclin study incorporates themes from Computational biology and Protein kinase A. Her Cyclin-dependent kinase 2 research includes themes of Cancer research and Stereochemistry. Her Kinase study is concerned with Biochemistry in general.
Jane A. Endicott mainly focuses on Cyclin-dependent kinase, Cell biology, Binding site, Cell cycle and Cyclin-dependent kinase 1. Her study in Kinase extends to Cyclin-dependent kinase with its themes. Her Kinase research includes elements of Apoptosis, Transcription and Cyclin.
Her studies deal with areas such as Nuclear transport, Cell nucleus, Importin, Nuclear protein and Ankyrin repeat as well as Cell biology. Her Binding site research integrates issues from Adenosine triphosphate, Druggability, Pharmacophore, Stereochemistry and Structure–activity relationship. Her Cyclin-dependent kinase 1 research focuses on Cyclin-dependent kinase 2 and how it relates to Conformational energy, Non-competitive inhibition and Transferase.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The biochemistry of P-glycoprotein-mediated multidrug resistance.
Jane A. Endicott;Victor Ling.
Annual Review of Biochemistry (1989)
Protein kinase inhibitors: insights into drug design from structure.
Martin E. M. Noble;Jane A. Endicott;Louise N. Johnson.
Science (2004)
Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases.
Ralph Hoessel;Sophie Leclerc;Jane A. Endicott;Martin E. M. Nobel.
Nature Cell Biology (1999)
Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance
James H. Gerlach;Jane A. Endicott;Peter F. Juranka;Graham Henderson;Graham Henderson.
Nature (1986)
The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases
Nick R. Brown;Martin E. M. Noble;Jane A. Endicott;Louise N. Johnson.
Nature Cell Biology (1999)
The Structural Basis for Control of Eukaryotic Protein Kinases
Jane A. Endicott;Martin E.M. Noble;Louise N. Johnson.
Annual Review of Biochemistry (2012)
Protein kinase inhibition by staurosporine revealed in details of the molecular interaction with CDK2.
Alison M. Lawrie;Martin E.M. Noble;Paul Tunnah;Nicholas R. Brown.
Nature Structural & Molecular Biology (1997)
Molecular Basis for the Recognition of Phosphorylated and Phosphoacetylated Histone H3 by 14-3-3
Neil Macdonald;Julie P.I. Welburn;Martin E.M. Noble;Anhco Nguyen.
Molecular Cell (2005)
Identification of Novel Purine and Pyrimidine Cyclin-Dependent Kinase Inhibitors with Distinct Molecular Interactions and Tumor Cell Growth Inhibition Profiles.
C.E Arris;F.T Boyle;A.H Calvert;N.J Curtin.
Journal of Medicinal Chemistry (2000)
Effects of Phosphorylation of Threonine 160 on Cyclin-dependent Kinase 2 Structure and Activity
Nicholas R. Brown;Martin E.M. Noble;Alison M. Lawrie;May C. Morris.
Journal of Biological Chemistry (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Newcastle University
University of Oxford
Newcastle University
Perha Pharmaceuticals
BC Cancer Research Centre
RMIT University
University of Oxford
University of Nottingham
King Abdullah University of Science and Technology
The Francis Crick Institute
Amazon (Germany)
Czech Technical University in Prague
Sun Yat-sen University
University of Washington
Rockwell Automation (United States)
Oregon State University
University of the Balearic Islands
University of Helsinki
University of Bordeaux
University of Antwerp
SUNY Downstate Medical Center
Dalhousie University
University of Southern California
University of Colorado Boulder
University of Warwick
University of Pavia